ASHLEY STOVALL: Open Payments
NPI 1174165153 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,833 in 113 payments from 22 companies in 2025. Trend: 2023 $32 · 2024 $316 · 2025 $1,833
Food & beverage: $1,833
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $378 |
| Novo Nordisk Inc | 20 | $370 |
| Amgen Inc. | 22 | $163 |
| Lilly USA, LLC | 8 | $136 |
| AstraZeneca Pharmaceuticals LP | 7 | $119 |
| DePuy Synthes Sales Inc. | 1 | $91 |
| Ardelyx, Inc. | 3 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Verona Pharma, Inc. | 2 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
Products named: Ozempic, QULIPTA, MOUNJARO, Rybelsus, OTEZLA, UBRELVY, VRAYLAR, NA.
Industry payments across TX — which companies pay providers there.
